Immunohistochemical localization of FGF-5 and VEGF in epiretinal membranes

Research output: Contribution to journalArticle

Abstract

Purpose. Proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy (PDR) remain the two most common intraocular proliferative diseases with devastating outcome. Growth factors are thought to play an important role in the pathogenesis of these diseases. Apart the better known Fibroblast Growth Factor-1 and -2 (FGF-1 and -2), little is known about FGF-5. Vascular Endothelial Growth Factor (VEGF) is known to be primarily involved in vascular proliferative diseases, whereas little is known in terms of avascular diseases. In order to determine their role in the mentioned diseases we performed immunohistochemical stainings of epiretinal membranes. Methods. Human surgical specimens of epiretinal membranes were obtained trom 11 eyes with PDR and 3 eyes with PVR, fixed in 4% buffered paraformaldehyde and embedded in immunobed. Sections were immunostained with an affinity-purified antibody against an internal sequence of FGF-5 and with a commercially available affinity-purified antibody corresponding to the first 20 residues of human VEGF. Slides were visualized using the ABC-System (Avidin-Biotin-Peroxidase Complex) Control studies were performed with non-immune IgG and preabsorbed VEGF antibody respectively. Results. The results of these studies indicate that immunoreactive FGF-5 is present in most cells of vascular (including endothelial cells) and avascular membranes, but is absent in extracellular matrix. A similar staining pattern could be observed for VEGF. Conclusions. These two proteins are remarkably co-expressed in both vascular and avascular epiretinal membranes arising from PDR and PVR, respectively. This result questions the idea that the presence of a single angiogenic factor determines the vascular status of an epiretinal proliferation.

Original languageEnglish (US)
JournalInvestigative Ophthalmology and Visual Science
Volume37
Issue number3
StatePublished - Feb 15 1996

Fingerprint

Epiretinal Membrane
Proliferative Vitreoretinopathy
Vascular Endothelial Growth Factor A
Diabetic Retinopathy
Fibroblast Growth Factor 1
Antibody Affinity
Fibroblast Growth Factor 2
Blood Vessels
Staining and Labeling
Avidin
Angiogenesis Inducing Agents
Biotin
Vascular Diseases
Peroxidase
Extracellular Matrix
Intercellular Signaling Peptides and Proteins
Endothelial Cells
Immunoglobulin G
Cell Membrane
Antibodies

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Immunohistochemical localization of FGF-5 and VEGF in epiretinal membranes. / Schneeberger, S. A.; Hjelmeland, Leonard M; Morse, Lawrence S.

In: Investigative Ophthalmology and Visual Science, Vol. 37, No. 3, 15.02.1996.

Research output: Contribution to journalArticle

@article{4b622f6b1ade4494a47d628f913b7766,
title = "Immunohistochemical localization of FGF-5 and VEGF in epiretinal membranes",
abstract = "Purpose. Proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy (PDR) remain the two most common intraocular proliferative diseases with devastating outcome. Growth factors are thought to play an important role in the pathogenesis of these diseases. Apart the better known Fibroblast Growth Factor-1 and -2 (FGF-1 and -2), little is known about FGF-5. Vascular Endothelial Growth Factor (VEGF) is known to be primarily involved in vascular proliferative diseases, whereas little is known in terms of avascular diseases. In order to determine their role in the mentioned diseases we performed immunohistochemical stainings of epiretinal membranes. Methods. Human surgical specimens of epiretinal membranes were obtained trom 11 eyes with PDR and 3 eyes with PVR, fixed in 4{\%} buffered paraformaldehyde and embedded in immunobed. Sections were immunostained with an affinity-purified antibody against an internal sequence of FGF-5 and with a commercially available affinity-purified antibody corresponding to the first 20 residues of human VEGF. Slides were visualized using the ABC-System (Avidin-Biotin-Peroxidase Complex) Control studies were performed with non-immune IgG and preabsorbed VEGF antibody respectively. Results. The results of these studies indicate that immunoreactive FGF-5 is present in most cells of vascular (including endothelial cells) and avascular membranes, but is absent in extracellular matrix. A similar staining pattern could be observed for VEGF. Conclusions. These two proteins are remarkably co-expressed in both vascular and avascular epiretinal membranes arising from PDR and PVR, respectively. This result questions the idea that the presence of a single angiogenic factor determines the vascular status of an epiretinal proliferation.",
author = "Schneeberger, {S. A.} and Hjelmeland, {Leonard M} and Morse, {Lawrence S}",
year = "1996",
month = "2",
day = "15",
language = "English (US)",
volume = "37",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - Immunohistochemical localization of FGF-5 and VEGF in epiretinal membranes

AU - Schneeberger, S. A.

AU - Hjelmeland, Leonard M

AU - Morse, Lawrence S

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Purpose. Proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy (PDR) remain the two most common intraocular proliferative diseases with devastating outcome. Growth factors are thought to play an important role in the pathogenesis of these diseases. Apart the better known Fibroblast Growth Factor-1 and -2 (FGF-1 and -2), little is known about FGF-5. Vascular Endothelial Growth Factor (VEGF) is known to be primarily involved in vascular proliferative diseases, whereas little is known in terms of avascular diseases. In order to determine their role in the mentioned diseases we performed immunohistochemical stainings of epiretinal membranes. Methods. Human surgical specimens of epiretinal membranes were obtained trom 11 eyes with PDR and 3 eyes with PVR, fixed in 4% buffered paraformaldehyde and embedded in immunobed. Sections were immunostained with an affinity-purified antibody against an internal sequence of FGF-5 and with a commercially available affinity-purified antibody corresponding to the first 20 residues of human VEGF. Slides were visualized using the ABC-System (Avidin-Biotin-Peroxidase Complex) Control studies were performed with non-immune IgG and preabsorbed VEGF antibody respectively. Results. The results of these studies indicate that immunoreactive FGF-5 is present in most cells of vascular (including endothelial cells) and avascular membranes, but is absent in extracellular matrix. A similar staining pattern could be observed for VEGF. Conclusions. These two proteins are remarkably co-expressed in both vascular and avascular epiretinal membranes arising from PDR and PVR, respectively. This result questions the idea that the presence of a single angiogenic factor determines the vascular status of an epiretinal proliferation.

AB - Purpose. Proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy (PDR) remain the two most common intraocular proliferative diseases with devastating outcome. Growth factors are thought to play an important role in the pathogenesis of these diseases. Apart the better known Fibroblast Growth Factor-1 and -2 (FGF-1 and -2), little is known about FGF-5. Vascular Endothelial Growth Factor (VEGF) is known to be primarily involved in vascular proliferative diseases, whereas little is known in terms of avascular diseases. In order to determine their role in the mentioned diseases we performed immunohistochemical stainings of epiretinal membranes. Methods. Human surgical specimens of epiretinal membranes were obtained trom 11 eyes with PDR and 3 eyes with PVR, fixed in 4% buffered paraformaldehyde and embedded in immunobed. Sections were immunostained with an affinity-purified antibody against an internal sequence of FGF-5 and with a commercially available affinity-purified antibody corresponding to the first 20 residues of human VEGF. Slides were visualized using the ABC-System (Avidin-Biotin-Peroxidase Complex) Control studies were performed with non-immune IgG and preabsorbed VEGF antibody respectively. Results. The results of these studies indicate that immunoreactive FGF-5 is present in most cells of vascular (including endothelial cells) and avascular membranes, but is absent in extracellular matrix. A similar staining pattern could be observed for VEGF. Conclusions. These two proteins are remarkably co-expressed in both vascular and avascular epiretinal membranes arising from PDR and PVR, respectively. This result questions the idea that the presence of a single angiogenic factor determines the vascular status of an epiretinal proliferation.

UR - http://www.scopus.com/inward/record.url?scp=33750187722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750187722&partnerID=8YFLogxK

M3 - Article

VL - 37

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -